GlucoLight Corporation Unveils Ergonomic Improvements and Performance Enhancements to SENTRIS-100(TM) Glucose Monitor
12/18/2007 2:39:56 PM
BETHLEHEM, Pa.--(BUSINESS WIRE)--GlucoLight Corporation, a development-stage company focused on non invasive blood glucose monitoring in the acute care environment, today unveiled design and performance enhancements to the company’s first product, the SENTRIS-100™ glucose monitor. The enhancements to SENTRIS-100™ include changes in both design and functionality.
comments powered by